このエピソードについて

英語
アメリカ合衆国

文字起こし 🔗

過去のエピソードを検索

ASTRO 2015の以前のエピソードを検索します。

このポッドキャストの他のエピソード

Dr Hong talks to ecancertv at ASTRO 2015 about a prospective, open-label phase II, study of proton-based stereotactic body radiotherapy (SBRT) in patients with liver metastases. The study findings showed that proton SBRT was associated with high rates of local control and that there was a favourab…
Dr Hoyer talks to ecancertv at ASTRO 2015 about his lecture during the ASTRO/ESTRO Joint Session 'Novel treatment approaches for oligometastases'. In the interview he provides background on how oligometastases have been managed in the past and how stereotactic body radiation therapy (SBRT) is bein…
Dr Abazeed talks to ecancertv at ASTRO 2015 about research being conducted at the Cleveland Clinic looking at whether it is possible to use genomic parameters to predict how tumours will respond to radiation therapy. In the interview he highlights that there is an underlying genetic diversity of c…
Dr Hong talks to ecancertv about one of the nursing sessions held at ASTRO 2015 that looked at the care of patients receiving chemoradiation. In the interview he outlines that the aims of the session were to provide an overview of the data and rationale for why certain chemoradiation strategies we…
Mr DiGiaimo talks to ecancertv at ASTRO 2015 about some of his research highlights and the potential economic considerations of using newer radiation technologies over conventional standards.
免責: このページに埋め込まれているポッドキャストとアートワークは ecancer.org からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。